Cardinal Well being (NYSE: CAH), a number one prescribed drugs distributor, on Wednesday reported a rise in revenues and adjusted revenue for the fourth quarter of 2024.
- Fourth quarter income elevated 12% year-over-year to $59.9 billion, primarily reflecting robust gross sales development within the core enterprise phase
- Income for the Pharmaceutical and Specialty Options phase elevated 13% to $55.6 billion in This autumn
- The World Medical Merchandise and Distribution phase elevated by 2% to $3.1 billion throughout the three months
- Working earnings greater than tripled to $401 million within the fourth quarter
- Web earnings, on a reported foundation, was $235 million or $0.96 per share in This autumn, vs. a lack of $56 million or $0.22 per share a 12 months earlier
- Adjusted earnings elevated 29% to $1.84 per share from $1.43 per share within the prior-year quarter
- Within the full fiscal 12 months, working money move and adjusted free money move reached all-time highs of $3.8 billion and $3.9 billion, respectively
- The corporate raised adjusted EPS steering for fiscal 2025 to $7.55-$7.70 from the earlier forecast of ‘at the least’ $7.50
